Skip to content ↓

Reception, biotech convention draw MIT and worldwide participants

MIT President Susan Hockfield welcomes Dato' Sri Mohd Najib Tun Abdul Razak, deputy prime minister of Malaysia, to a reception she hosted to welcome participants to the 2007 BIO International Convention held in Boston, May 6-9. <a onclick="MM_openBrWindow('bio-1-enlarged.html','','width=509, height=583')">
<span onmouseover="this.className='cursorChange';">Open image gallery</span>
</a>
<noscri...
Caption:
MIT President Susan Hockfield welcomes Dato' Sri Mohd Najib Tun Abdul Razak, deputy prime minister of Malaysia, to a reception she hosted to welcome participants to the 2007 BIO International Convention held in Boston, May 6-9. <a onclick="MM_openBrWindow('bio-1-enlarged.html','','width=509, height=583')">
<span onmouseover="this.className='cursorChange';">Open image gallery</span>
</a>
<noscript> <a href="bio-1-enlarged.html">
<em>(no JavaScript)</em>
</a>
</noscript>
Credits:
Photo / Justin Knight

Dato' Sri Mohd Najib Tun Abdul Razak, deputy prime minister of Malaysia, was among the guests at a reception hosted by President Susan Hockfield to welcome participants to the 2007 BIO International Convention held in Boston May 6-9.

Produced by the Biotechnology Industry Organization (BIO), the conference drew a record 22,366 attendees representing 48 states. One-third of attendees came from outside the United States.

Event highlights included keynote addresses from Michael J. Fox, founder of the Michael J. Fox Foundation for Parkinson's Research, and Her Majesty Queen Noor of Jordan. Fox, who appeared before a packed room, urged the biotechnology industry to continue to innovate and accelerate the translation of basic science into improved therapies for patients. Queen Noor discussed the opportunities presented by biotechnology to address global health and poverty issues.

The final keynote session, "A Hopeful Future: Gaining the Edge with Biotechnology," featured Institute Professors Robert S. Langer and Phillip A. Sharp as panelists. They joined Craig C. Mello of the University of Massachusetts Medical School and author Virginia Postrel in discussing their visions of the future of the biotechnology industry.

Sharp noted that the United States has no monopoly on biotechnology. "There is science in Europe, Asia and elsewhere. I see us as having increasing competition ... biotech is something we have to keep competing at," he said.

A version of this article appeared in MIT Tech Talk on May 16, 2007 (download PDF).

Related Links

Related Topics

More MIT News

Globular blue and white orbs "examining" single-stranded RNA products and marking them with green checks or red x's

Why are some bacterial genes high in purines?

In certain species of bacteria, the answer lies in shielding RNA transcripts from a quality-control factor called Rho. Understanding the requirements for expressible sequences is critical for expression engineering of therapeutic agents.

Read full story

Rich Nielsen, Volha Charnysh, Kevin Dorst, and Emily Richmond Pollock seated at a table, talking

Building a scholarly community

The SHASS Faculty Fellows Program, administered by the MIT Human Insight Collaborative, is fostering new research projects and creating space for supportive and interdisciplinary discussion.

Read full story